[Normobaric hypoxy-therapy of patients with bronchial asthma]. / Normobaricheskaia gipoksiterapiia bol'nykh bronkhial'noi astmoi.

Conventional drug therapy for moderate atopic or mixed bronchial asthma was combined with normobaric hypoxytherapy (NBHT) in 32 patients (a course of 10 sessions) and was not combined in 20 control patients. Clinical results show that NBHT enhances response to conventional therapy of moderate bronchial asthma as confirmed by a significant relief of the clinical symptoms, by a significant rise of volumic and flow parameters of external respiration function, a fall in the number of CD 20+ B cells, low level of serum IgE, increased number of phagocyting neutrophils and cells carrying erythroblast antigen in peripheral blood.

[Effect of microsomal monooxygenase inductor zixoryn on clinico-immunologic indicators in allergologic patients]. / Vliianie induktora mikrosomal'nykh monooksigenaz ziksorina na kliniko-immunologicheskie pokazateli u allergologicheskikh bol'nykh.

Zixorine, an inducer of microsomal monoxygenases, can effectively be used for the treatment of patients with allergic dermatoses. It has been established that zixorine makes the NBT-test and the IgE content in the blood serum of these patients return to normal.